Status:
WITHDRAWN
Motor Deficits and Signal Conduction in Individuals With Williams Syndrome
Lead Sponsor:
Sheba Medical Center
Collaborating Sponsors:
Tel Aviv University
Conditions:
Williams Syndrome
Eligibility:
All Genders
3-30 years
Brief Summary
The current study aims to validate basic research findings of abnormal conductivity and motor abilities from a mouse model in humans. The study will measure nerve conduction properties in WS individua...
Detailed Description
50 individuals with WS will take part in the study. All participants will be recruited from the Williams Syndrome Clinic at Edmond and Lili Safra Children's Hospital, Sheba Medical Center directed by ...
Eligibility Criteria
Inclusion
- WS patients.
Exclusion
- WS patients suffering from additional neurological condition (such as epilepsy).
- Participants who will have difficulties preforming the tests may ask to be excluded.
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2030
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05430763
Start Date
February 1 2023
End Date
August 1 2030
Last Update
June 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv University
Tel Aviv, Israel